Gladstone welcomes inquiries from journalists. Our media relations staff is on hand to provide local, regional, national, and international journalists with accurate information about Gladstone’s research and our investigators’ areas of expertise. We are available to arrange interviews with Gladstone scientists and assist in developing story ideas.
Contact
For media inquiries or interview requests, email media-relations@gladstone.org
Kelly Quigley
Director, Science Communications & Media Relations
Direct line: 858-997-9462
Email
Julie Langelier
Associate Director, Communications
Direct line: 415-734-5000
Email
News Releases
1 - 15 of 201 Results
Gladstone Researchers Discover How Chronic Inflammation Worsens Heart Failure
Gladstone Researchers Discover How Chronic Inflammation Worsens Heart Failure
The new findings have implications for developing immune therapies that target heart disease and chronic conditions in other organs.
News Release Research (Publication) Heart Failure Cardiovascular Disease Alexanian Lab Srivastava LabGladstone to Present 2024 Ogawa-Yamanaka Stem Cell Prize to Neuroscientist Rusty Gage
Gladstone to Present 2024 Ogawa-Yamanaka Stem Cell Prize to Neuroscientist Rusty Gage
Gage has reshaped our understanding of stem cells in the adult brain with landmark discoveries that may contribute to the development of new or better therapies for neurological disorders.
Awards Institutional News News Release Ogawa Stem Cell Prize Stem Cells/iPSCsA New Era of Treating Neurological Diseases at the Blood-Brain-Immune Interface
A New Era of Treating Neurological Diseases at the Blood-Brain-Immune Interface
Gladstone scientists say it’s time to think differently about how to define and treat diseases such as Alzheimer’s and multiple sclerosis.
News Release Research (Publication) Alzheimer’s Disease Dementia Multiple Sclerosis Parkinson’s Disease Neurological Disease Akassoglou LabClosing the Loopholes of Current HIV Therapy
Closing the Loopholes of Current HIV Therapy
Scientists say it may be possible to drive the virus into “deep latency” by targeting the cellular process of transcription, by which lingering HIV cells continue to produce viral components.
News Release Research (Publication) HIV/AIDS Virology Ott LabHarnessing the Power of Phages to Defeat Drug-Resistant Infections
Harnessing the Power of Phages to Defeat Drug-Resistant Infections
Virologist Sukrit Silas hopes to turn bacteria-killing viruses into new therapies that hold promise against even the most persistent superbugs.
News Release Profile VirologyGladstone Presents Inaugural Sobrato Prize in Neuroscience to Yadong Huang, a Pioneer of Alzheimer’s Research
Gladstone Presents Inaugural Sobrato Prize in Neuroscience to Yadong Huang, a Pioneer of Alzheimer’s Research
The prize will be awarded annually to a Gladstone scientist who has made breakthrough discoveries in brain research; funds will help advance scientific discoveries from the lab to the clinic.
Awards News Release Alzheimer’s Disease Neurological Disease Huang Lab Aging Human GeneticsBuilding Better DNA Editors: Retrons Raise the Bar for Gene Research
Building Better DNA Editors: Retrons Raise the Bar for Gene Research
Gladstone scientists undertake a major effort to examine the diversity of retrons, bacterial defense systems that can be leveraged for precise gene editing
News Release Research (Publication) Data Science and Biotechnology Shipman LabNew Technology Could Lead to Alternative Treatments for Antibiotic-Resistant Bacteria
New Technology Could Lead to Alternative Treatments for Antibiotic-Resistant Bacteria
Scientists at Gladstone Institutes develop a streamlined and rapid way to engineer bacteria-fighting viruses known as phages
News Release Research (Publication) Data Science and Biotechnology Shipman Lab CRISPR/Gene EditingGladstone Institutes Launches Capital Campaign to Accelerate a Biomedical Revolution
Gladstone Institutes Launches Capital Campaign to Accelerate a Biomedical Revolution
The $350 million Gladstone NOW campaign will raise funds to expand Gladstone’s footprint, hire hundreds of additional scientists, and seize emerging opportunities for high-impact biomedical research that can overcome disease.
Philanthropy Institutional News News ReleaseGladstone’s Catherine Tcheandjieu Gueliatcha Named an ‘Emerging Leader’ by National Academy of Medicine
Gladstone’s Catherine Tcheandjieu Gueliatcha Named an ‘Emerging Leader’ by National Academy of Medicine
Tcheandjieu is one of 10 scholars nationwide selected as an emerging leader who's shaping the future of health and medicine.
Awards News Release Heart Failure Data Science and Biotechnology Tcheandjieu Lab AI Big DataDiscovery of How Blood Clots Harm Brain and Body in COVID-19 Points to New Therapy
Discovery of How Blood Clots Harm Brain and Body in COVID-19 Points to New Therapy
A new study in Nature overturns the prevailing theory that blood clotting is merely a consequence of inflammation in COVID-19.
News Release Research (Publication) COVID-19 Neurological Disease Virology Akassoglou Lab3D Shapes of Viral Proteins Point to Previously Unknown Roles
3D Shapes of Viral Proteins Point to Previously Unknown Roles
Scientists uncover an ancient immune-evading strategy shared by animal viruses and viruses that infect bacteria; findings may help in the development of new antiviral therapies
News Release Research (Publication) Data Science and Biotechnology Virology Doudna Lab CRISPR/Gene EditingPreventing Brain Damage in Preterm Babies
Preventing Brain Damage in Preterm Babies
Researchers identify a root cause of developmental delays that result from brain bleeds in premature infants, opening a path for new therapeutic strategies to counter long-term health risks
News Release Research (Publication) Neurological Disease Center for Neurovascular Brain Immunology Akassoglou LabNew One-Step Method to Make Multiple Edits to a Cell’s Genome
New One-Step Method to Make Multiple Edits to a Cell’s Genome
Scientists at Gladstone develop a more efficient way to make several, precise edits simultaneously to human cells
News Release Research (Publication) Data Science and Biotechnology Shipman Lab CRISPR/Gene EditingJustin Eyquem Named a 2024 Pew-Stewart Scholar for Cancer Research
Justin Eyquem Named a 2024 Pew-Stewart Scholar for Cancer Research
Eyquem, an affiliate investigator at Gladstone Institutes, is working to enhance the efficiency of CAR-T therapy, a cancer treatment that modifies T cells to target cancer cells.
Awards News Release Cancer Eyquem Lab
